文献速递妇科

ACOG 第734号委员会意见:经阴道超声在评估绝经后出血妇女子宫内膜中的作用

ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding.
PubMed 文献 · Obstet Gynecol · 2018-01-01

该委员会意见指出,阴道出血是绝经后子宫内膜癌患者最常见的首发症状,经阴道超声检查若显示子宫内膜回声薄(≤4 mm),对子宫内膜癌的阴性预测值大于99%,可作为绝经后出血初步评估的合理首选方法;无出血的绝经后妇女偶然发现子宫内膜厚度>4 mm无需常规触发评估。

要点

  • 阴道出血是超过90%的绝经后子宫内膜癌患者的首发症状。
  • 子宫内膜厚度≤4 mm对子宫内膜癌的阴性预测值大于99%。
  • 经阴道超声可作为绝经后首次出血评估的合理首选方法。

核心结论

  • 经阴道超声检查若显示子宫内膜回声薄(≤4 mm),通常足以对绝经后出血进行初步评估,因为子宫内膜厚度4 mm或以下对子宫内膜癌的阴性预测值大于99%。
  • 经阴道超声检查是评估绝经后妇女首次出血发作时替代子宫内膜取样的合理首选方法。
  • 如果盲法取样未显示子宫内膜增生或恶性肿瘤,对于持续或反复出血的妇女,需进行进一步检查,如宫腔镜检查加刮宫。
  • 无出血的绝经后患者偶然发现子宫内膜测量值大于4 mm无需常规触发评估,但基于患者特征和风险因素的个体化评估是适当的。
  • 经阴道超声检查不是无出血绝经后妇女子宫内膜癌的适当筛查工具。

研究设计与样本

  • 美国妇产科医师学会(ACOG)发布的委员会意见。

主要发现

  • 阴道出血是超过90%的绝经后子宫内膜癌患者的首发症状。
  • 子宫内膜厚度4 mm或以下对子宫内膜癌的阴性预测值大于99%。

关键数值与推荐

  • 经阴道超声显示子宫内膜回声≤4 mm通常足以进行绝经后出血的初步评估。
  • 经阴道超声检查是评估绝经后妇女首次出血发作时替代子宫内膜取样的合理首选方法。
  • 盲法取样未显示子宫内膜增生或恶性肿瘤时,对持续或反复出血的妇女需进行宫腔镜检查加刮宫等进一步检查。
  • 无出血的绝经后患者偶然发现子宫内膜测量值>4 mm无需常规触发评估,但适合基于患者特征和风险因素的个体化评估。
  • 经阴道超声检查不是无出血绝经后妇女子宫内膜癌的适当筛查工具。

临床怎么用

  • 评估绝经后出血时需考虑子宫内膜癌的临床风险因素,包括但不限于年龄、肥胖、使用无对抗雌激素、特定医学合并症(如多囊卵巢综合征、2型糖尿病、宫颈细胞学筛查显示非典型腺细胞)以及妇科恶性肿瘤家族史。
  • 对绝经后出血的临床处理需要及时有效的评估,以排除或诊断子宫内膜癌和子宫内膜上皮内瘤变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cancer of the endometrium is the most common type of gynecologic cancer in the United States. Vaginal bleeding is the presenting sign in more than 90% of postmenopausal women with endometrial carcinoma. Clinical risk factors for endometrial cancer, including but not limited to age, obesity, use of unopposed estrogen, specific medical comorbidities (eg, polycystic ovary syndrome, type 2 diabetes mellitus, atypical glandular cells on screening cervical cytology), and family history of gynecologic malignancy also should be considered when evaluating postmenopausal bleeding. The clinical approach to postmenopausal bleeding requires prompt and efficient evaluation to exclude or diagnose endometrial carcinoma and endometrial intraepithelial neoplasia. Transvaginal ultrasonography usually is sufficient for an initial evaluation of postmenopausal bleeding if the ultrasound images reveal a thin endometrial echo (less than or equal to 4 mm), given that an endometrial thickness of 4 mm or less has a greater than 99% negative predictive value for endometrial cancer. Transvaginal ultrasonography is a reasonable alternative to endometrial sampling as a first approach in evaluating a postmenopausal woman with an initial episode of bleeding. If blind sampling does not reveal endometrial hyperplasia or malignancy, further testing, such as hysteroscopy with dilation and curettage, is warranted in the evaluation of women with persistent or recurrent bleeding. An endometrial measurement greater than 4 mm that is incidentally discovered in a postmenopausal patient without bleeding need not routinely trigger evaluation, although an individualized assessment based on patient characteristics and risk factors is appropriate. Transvaginal ultrasonography is not an appropriate screening tool for endometrial cancer in postmenopausal women without bleeding.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. ACOG Committee Opinion No. 734: The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmenopausal Bleeding. Obstet Gynecol. 2018. PMID: 29683909. doi:10.1097/AOG.0000000000002631

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。